C Tausch

Abstract GS3-01: A prospective randomized multi-center phase-III trial of additional 2 versus additional 5 years of anastrozole after initial 5 years of adjuvant endocrine therapy – results from 3,484 postmenopausal women in the ABCSG-16 trial

Michael Gnant, G. Steger, Richard Greil et al. · Cancer Research · 2018 · 37 citations

Breast Oncology, Adjuvant Chemotherapy, Gynecology +21

The impact of preoperative breast biopsy on the risk of sentinel lymph node metastases: analysis of 2502 cases from the Austrian sentinel node biopsy study group

C Peters-Engl, P. Konstantiniuk, C Tausch et al. · British Journal of Cancer · 2004 · 32 citations · Full text

Tamoxifen and anastrozole as a sequencing strategy in postmenopausal women with hormone-responsive early breast cancer: updated data from the Austrian breast and colorectal cancer study group trial 8.

R. Jakesz, Michael Gnant, R Griel et al. · Cancer Research · 2009 · 29 citations

Breast Oncology, Cancer Management, Gynecology +19

6 vs. 3 cycles of epirubicin/docetaxel + G-CSF in operable breast cancer: results of ABCSG-14

Guenther G. Steger, E. Kubista, H. Hausmaninger et al. · Journal of Clinical Oncology · 2004 · 19 citations

Surgical Oncology, Breast Oncology, Cancer Management +17

Factors Affecting Identification Rate and Positivity of the Sentinel Node in Breast Cancer in 1567 Patients, Using Blue Dye and 99 mTc-Labelled Colloid, Based on a Multicentre Database Project in Austria

Barbara Pichler-Gebhard, P. Konstantiniuk, C Tausch et al. · European surgery. Supplement/European surgery · 2002 · 16 citations

Blue Dye, Breast Oncology, Sentinel Node +9